Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Beta Blocker · Unknown
Penbutolol is a non-selective beta-adrenergic receptor antagonist, blocking both β1 and β2 adrenoceptors. This blockade results in decreased heart rate and myocardial contractility due to β1 receptor antagonism, and can lead to effects like bronchoconstriction via β2 receptor antagonism.
Reduced efficacy of ritodrine and potential for adverse cardiovascular effects.
Ritodrine should not be used if the mother is receiving beta blockers.
Source: KDT 7e · p333
Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Hyperkalaemia more likely.
Source: KDT 7e
Exaggerated or prolonged bronchoconstriction and reduction in vital capacity in response to methacholine.
Emergency resuscitation equipment, oxygen, and medications to treat severe bronchospasm (e.g., β2 adrenergic receptor agonists for inhalation) should be available during testing.
Source: G&G 14e · p212
Severe bradycardia.
Extreme caution advised if amiodarone is co-administered with sofosbuvir and a beta blocker.
Source: Harrison 22e · unknown
Hyperkalaemia more likely.
Source: KDT 7e
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Increased propensity for AV block, severe bradycardia, and decreased left ventricular function.
Avoid concurrent administration. The concurrent administration of diltiazem with a beta blocker is contraindicated.
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Katzung·Verified: 2026-05-10 · House clinical team